Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - CERULEAN PHARMA INC (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Mar 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Mar 2015 ValuEngine, Inc. 11 $25.00

ValuEngine Industry Report for Medical-drugs(CERU)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Mar 2015 ValuEngine, Inc. 10 $49.00

CERULEAN - POSITIVE DATA ANNOUNCED FOR CRLX101 IN RCC

In conjunction with its FY14 results, Cerulean announced strong top-line interim data for CRLX101 in its lead indication of r...

20 Mar 2015 Edison Investment Research 2 $10.00

CERULEAN PHARMA (CERU) Zacks Company Snapshot

19 Mar 2015 Zacks Investment Research Inc. 1 $12.00

CERULEAN PHARMA (CERU) Zacks Company Snapshot

18 Mar 2015 Zacks Investment Research Inc. 1 $12.00

CERULEAN PHARMA (CERU) Zacks Company Snapshot

12 Mar 2015 Zacks Investment Research Inc. 1 $12.00

CERULEAN - UPCOMING PRICE INFLECTIONS ON CLINICAL PIPELINE

Cerulean is entering a rich newsflow period with multiple clinical junctures in the coming months. The company will announc...

09 Mar 2015 Edison Investment Research 2 $10.00

CERULEAN PHARMA (CERU) Zacks Company Snapshot

25 Feb 2015 Zacks Investment Research Inc. 1 $12.00